Skip to main content
MACH7 TECHNOLOGIES LIMITED logo

MACH7 TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · M7T ISIN · AU000000M7T0 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,192 across all filing types
Latest filing 2015-06-09 Board/Management Inform…
Country AU Australia
Listing ASX M7T

About MACH7 TECHNOLOGIES LIMITED

https://www.mach7t.com

Mach7 Technologies Limited specializes in enterprise imaging solutions for healthcare providers. The company develops software that enables the management, storage, and viewing of medical images and clinical data across diverse healthcare ecosystems. Its core offerings include the Mach7 Enterprise Imaging Platform, a Vendor Neutral Archive (VNA), and the eUnity Enterprise Viewer. These solutions are designed to provide a unified view of patient data, improving diagnostic workflows and clinical collaboration. Mach7's technology emphasizes interoperability, allowing integration with existing hospital systems and various imaging modalities. By decoupling data storage from viewing applications, the company offers a modular and scalable approach to medical data management, supporting large-scale healthcare networks and specialized diagnostic centers in optimizing their imaging infrastructure.

Recent filings

Filing Released Lang Actions
Company Secretary Appointment/Resignation 1 page 27
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 10 June 2015 regarding the appointment and resignation of the Company Secretary of 3D Medical Limited. It contains no financial data, no report or presentation, and no mention of voting results or dividends. The content is focused on management changes, specifically the appointment and resignation of a senior company officer. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2015-06-09 English
Genesis Cancer Care Research Collaboration Agreement 2 pages 363.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 9 June 2015 regarding a Research Collaboration Agreement between 3D Medical Limited and Genesis Cancer Care. It describes the nature of the collaboration, the goals, and potential outcomes but does not contain any financial statements, regulatory certifications, or detailed financial data. The document is relatively short (3544 characters) and serves as a public announcement of a business collaboration rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a report publication announcement since it does not mention any report being published or attached. The content is best classified as a general regulatory announcement about a business collaboration, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2015-06-08 English
Telstra Health Software Licence and Support Agreement signed 2 pages 142.8KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 4 June 2015 regarding a Software Licence and Support Agreement between 3D Medical Limited and Telstra Health. It discusses the commercial partnership, reseller rights, and planned commercial release. There are no financial statements, regulatory certifications, voting results, or management changes. The document is a corporate announcement about a business agreement and partnership, not a financial report, earnings release, or regulatory filing. It is also not a report publication announcement since it does not mention any report being published or attached. The content fits best under Capital/Financing Update (CAP) as it relates to a commercial agreement and business development that could impact the company's capital or financing outlook.
2015-06-03 English
Correction to escrow release notice 1 page 141.1KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement dated 29 May 2015 regarding the release of ordinary shares and options from escrow. It references ASX Listing Rule 3.10 and details specific dates and quantities of shares and options to be released from escrow. There is no financial report, earnings data, or management discussion present. The document is a regulatory announcement about share capital changes, specifically the release of shares/options from escrow, which is a capital structure event. This fits best under the category of Share Issue/Capital Change (SHA). The document length is short and it is not a report publication or certification, so it is not RPA or RNS. Therefore, the classification is SHA with high confidence.
2015-05-31 English
Release of shares and options from Escrow in June 2015 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 29 May 2015 regarding the release of ordinary shares and options from escrow. It references specific dates and quantities of shares and options being released from escrow pursuant to ASX Listing Rule 3.10. The content is a regulatory announcement about share capital changes, specifically the release of shares/options from escrow, which is a capital structure update. The document is short (1122 characters) and does not contain financial statements or detailed financial analysis. It is not a full report but an announcement about capital changes. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-05-28 English
Appointment of Chair and Resignation of Director 2 pages 93.0KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 28 May 2015 regarding the resignation of the Chairman and appointment of a new Chairman. It details changes in the company's board of directors, specifically the resignation of Mr Matthew Morgan and the appointment of Dr Nigel Finch as Chairman. There is no financial data, no mention of financial results, no audit information, no voting results, no legal proceedings, no capital changes, and no other report types. The content clearly fits the category of announcements about changes in the company's board or senior management.
2015-05-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.